102 related articles for article (PubMed ID: 9677578)
1. [Myofibroblasts and retinal fibrovascular membranes].
Pournaras CJ; Donati G; Kapetanios AD; Redard M; Bochatay-Piallat ML; Gabbiani G
Klin Monbl Augenheilkd; 1998 May; 212(5):356-8. PubMed ID: 9677578
[TBL] [Abstract][Full Text] [Related]
2. TGF-beta1, TGF-beta receptor II and ED-A fibronectin expression in myofibroblast of vitreoretinopathy.
Bochaton-Piallat ML; Kapetanios AD; Donati G; Redard M; Gabbiani G; Pournaras CJ
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2336-42. PubMed ID: 10892881
[TBL] [Abstract][Full Text] [Related]
3. [Electron-immunostaining characteristics of platelet-derived growth factor, transforming growth factor beta1 and their receptors in epiretinal membranes].
Wang F; Xu X; Zhang X; Yan Y
Zhonghua Yan Ke Za Zhi; 2000 Sep; 36(5):369-71, 24. PubMed ID: 11853632
[TBL] [Abstract][Full Text] [Related]
4. Pathological changes in the vitreoretinal junction 1: epiretinal membrane formation.
Snead DR; James S; Snead MP
Eye (Lond); 2008 Oct; 22(10):1310-7. PubMed ID: 18344963
[TBL] [Abstract][Full Text] [Related]
5. Myofibroblasts in proliferative diabetic retinopathy can originate from infiltrating fibrocytes and through endothelial-to-mesenchymal transition (EndoMT).
Abu El-Asrar AM; De Hertogh G; van den Eynde K; Alam K; Van Raemdonck K; Opdenakker G; Van Damme J; Geboes K; Struyf S
Exp Eye Res; 2015 Mar; 132():179-89. PubMed ID: 25637870
[TBL] [Abstract][Full Text] [Related]
6. [Ultrastructural characteristics of epiretinal membranes].
Wang F; Yan Y; Zhang X; Cai W
Zhonghua Yan Ke Za Zhi; 1999 Nov; 35(6):440-2, 24. PubMed ID: 11835856
[TBL] [Abstract][Full Text] [Related]
7. Retina-specific expression of PDGF-B versus PDGF-A: vascular versus nonvascular proliferative retinopathy.
Mori K; Gehlbach P; Ando A; Dyer G; Lipinsky E; Chaudhry AG; Hackett SF; Campochiaro PA
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):2001-6. PubMed ID: 12037011
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis and cell proliferation in proliferative retinal disorders: PCNA, Ki-67, caspase-3, and PARP expression.
Zhang X; Barile G; Chang S; Hays A; Pachydaki S; Schiff W; Sparrow J
Curr Eye Res; 2005 May; 30(5):395-403. PubMed ID: 16020270
[TBL] [Abstract][Full Text] [Related]
9. [Pathomorphology of membranes appearing in proliferative vitreoretinopathies].
Laudańska-Olszewska I; Omulecki W; Dziegielewski K; Pikulski Z; Omulecka A
Klin Oczna; 2006; 108(1-3):28-31. PubMed ID: 16883935
[TBL] [Abstract][Full Text] [Related]
10. [Comparative immunohistochemical studies of epiretinal membranes in proliferative vitreoretinal diseases].
Heidenkummer HP; Kampik A
Fortschr Ophthalmol; 1991; 88(3):219-24. PubMed ID: 1889766
[TBL] [Abstract][Full Text] [Related]
11. Proliferative retinal diseases: myofibroblasts cause chronic vitreoretinal traction.
Walshe R; Esser P; Wiedemann P; Heimann K
Br J Ophthalmol; 1992 Sep; 76(9):550-2. PubMed ID: 1420061
[TBL] [Abstract][Full Text] [Related]
12. Circulating fibrocytes contribute to the myofibroblast population in proliferative vitreoretinopathy epiretinal membranes.
Abu El-Asrar AM; Struyf S; Van Damme J; Geboes K
Br J Ophthalmol; 2008 May; 92(5):699-704. PubMed ID: 18441176
[TBL] [Abstract][Full Text] [Related]
13. [Immunohistochemical study on vitrectomy specimens of proliferative retinal diseases].
Cao J; Wu L; Zhang H
Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):264-7. PubMed ID: 10451957
[TBL] [Abstract][Full Text] [Related]
14. Evidence that neurites in human epiretinal membranes express melanopsin, calretinin, rod opsin and neurofilament protein.
Lesnik Oberstein SY; Lewis GP; Dutra T; Fisher SK
Br J Ophthalmol; 2011 Feb; 95(2):266-72. PubMed ID: 20971788
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta 1 promotes contraction of collagen gel by bovine corneal fibroblasts through differentiation of myofibroblasts.
Kurosaka H; Kurosaka D; Kato K; Mashima Y; Tanaka Y
Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):699-704. PubMed ID: 9538875
[TBL] [Abstract][Full Text] [Related]
16. Different expression of vascular endothelial growth factor and pigment epithelium-derived factor between diabetic and non-diabetic epiretinal membranes.
Nam DH; Oh J; Roh JH; Huh K
Ophthalmologica; 2009; 223(3):188-91. PubMed ID: 19182495
[TBL] [Abstract][Full Text] [Related]
17. [Contractile elements in proliferative retinal diseases].
Molitor R; Esser P; Weller M; Wiedemann P; Heimann K
Ophthalmologe; 1992 Feb; 89(1):34-8. PubMed ID: 1581690
[TBL] [Abstract][Full Text] [Related]
18. Expression of autotaxin and acylglycerol kinase in proliferative vitreoretinal epiretinal membranes.
Abu El-Asrar AM; Missotten L; Geboes K
Acta Ophthalmol; 2012 Mar; 90(2):e84-9. PubMed ID: 22103573
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of angiogenesis and proliferative activity in epiretinal membranes.
Tsanou E; Ioachim E; Stefaniotou M; Gorezis S; Charalabopoulos K; Bagli H; Peschos D; Psilas K; Agnantis NJ
Int J Clin Pract; 2005 Oct; 59(10):1157-61. PubMed ID: 16178982
[TBL] [Abstract][Full Text] [Related]
20. The role of gremlin, a BMP antagonist, and epithelial-to-mesenchymal transition in proliferative vitreoretinopathy.
Lee H; O'Meara SJ; O'Brien C; Kane R
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4291-9. PubMed ID: 17724219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
